Kong Y N, Jin J, Cheng B
Department of Plastic Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Department of Burns and Plastic Surgery, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China.
Zhonghua Shao Shang Za Zhi. 2020 Dec 20;36(12):1173-1182. doi: 10.3760/cma.j.cn501120-20200325-00194.
To investigate the effects and mechanism of sympathetic neurotransmitter norepinephrine (NE) on the migration of bone marrow mesenchymal stem cells (BMSCs) in mice. (1) Twenty 3-week-old male C57BL/6 mice were sacrificed for isolating, culturing, and identifying BMSCs from the femur and tibia. Cells of the second or third passages were divided into phosphate buffer solution (PBS) group, 1 μmol/L NE group, 10 μmol/L NE group, and 100 μmol/L NE group, with 8 wells in each group. Cells in 1 μmol/L NE group, 10 μmol/L NE group, and 100 μmol/L NE group were cultured in low-sugar Dulbecco's modified eagle medium containing 1% volume fraction of fetal bovine serum (hereinafter referred to as low-serum medium) added with NE in final molarity of 1 μmol/L, 10 μmol/L, and 100 μmol/L, respectively. Cells in PBS group were cultured in low-serum medium added with the same volume of PBS. Before stimulation (0 d) and on stimulation day 1, 3, 5, cell counting kit 8 method was used to detect cell proliferation activity (expressed as the absorbance value). (2) In cell scratch test 1, cells were divided into PBS group and simple NE group. After the scratch test, cells in simple NE group were cultured with low-serum medium+ NE in final molarity of 10 μmol/L, and cells in PBS group were cultured with low-serum medium+ the same volume of PBS. In cell scratch test 2, cells were divided into PBS group, propranolol+ NE group, and phentolamine+ NE group. After the scratch test, cells in propranolol+ NE group were pretreated with low-serum medium+ propranolol in final molarity of 1 μmol/L for 30 minutes each day, cells in phentolamine+ NE group were pretreated with low-serum medium+ phentolamine in final molarity of 10 μmol/L for 30 minutes each day, and then they were cultured with low-serum medium+ NE in final molarity of 10 μmol/L. Cells in PBS group were cultured with low-serum medium+ the same volume of PBS. In cell scratch test 3, cells were divided into simple NE group, simple (2E, 6E)-2, 6-bis (4-pyridylmethylene) cyclohexanone (SC-66) group, and SC-66+ NE group. After the scratch test, cells in simple NE group was cultured with low-serum medium+ NE in final molarity of 10 μmol/L, cells in simple SC-66 group were cultured with low-serum medium after being pretreated with SC-66 in final molarity of 30 mmol/L for 30 minutes every day, cells in SC-66+ NE group were cultured with low-serum medium+ NE in final molarity of 10 μmol/L after being pretreated with SC-66 in final molarity of 30 mmol/L for 30 minutes every day. In the above 3 cell scratch tests, the sample numbers in each group were all 6, and the scratch healing rates at post scratch hour (PSH) 24, 48, and 72 were all calculated. (3) Cells were divided into PBS group, simple NE group, propranolol+ NE group, and phentolamine+ NE group, with 3 wells in each group. The lower chamber treatment methods of PBS group and simple NE group were the same as those of the same groups in cell scratch test 1. The lower chamber treatment of propranolol+ NE group and phentolamine+ NE group were the same as those of the same groups in cell scratch test 2. After the Transwell experiment was performed and the cells were routinely cultured for 24 hours, the migrated cells were counted. (4) Cells were divided into PBS group, simple NE group, propranolol+ NE group, and phentolamine+ NE group, with 2 dishes in each group. The cell treatment of PBS group and simple NE group were the same as those of the same groups in cell scratch test 1. The cell treatment of propranolol+ NE group and phentolamine+ NE group were the same as those of the same groups in cell scratch test 2. After 24 hours of routine culture, the phosphorylation level of protein kinase B (Akt) of cells was detected by Western blotting. Data were statistically analyzed with analysis of variance for repeated measurement, one-way analysis of variance, independent sample test, least significant difference test, and Bonferroni correction. (1) After 1 day of stimulation, the absorbance value of cells in 100 μmol/L NE group was significantly lower than that in PBS group (=2.986, <0.05). After 5 days of stimulation, the absorbance value of cells in 10 μmol/L NE group was significantly higher than that in PBS group (=3.547, <0.01). (2) In cell scratch test 1, at PSH 24, 48, and 72, the scratch healing rates of cells in simple NE group were (34.4±3.4)%, (52.5±4.7)%, and (70.0±3.8)%, which were significantly lower than (44.1±4.2)%, (80.0±3.6)%, and (95.9±2.2)% in PBS group (=19.320, 128.319, 221.575, <0.01). In cell scratch test 2, at PSH 24, 48, and 72, the scratch healing rates of cells in propranolol+ NE group were significantly lower than those in PBS group (=4.073, 9.618, 15.272, <0.01). In cell scratch test 3, at PSH 72, the scratch healing rates of cells in NE group was significantly lower than that in simple SC-66 group (=8.862, <0.01). At PSH 24, 48, and 72, the scratch healing rates of cells in SC-66+ NE group were significantly lower than those in simple SC-66 group (=3.862, 4.290, 10.357, <0.01). (3) The Transwell experiment showed that after 24 hours of culture, the numbers of migrated cells in simple NE group, propranolol+ NE group, and phentolamine+ NE group were significantly less than the number in PBS group (=11.895, 10.196, 3.222, <0.01). (4) After 24 hours of culture, the phosphorylation levels of Akt of cells in simple NE group and propranolol+ NE group were significantly higher than the level in PBS group (=8.186, 5.996, <0.01). NE can inhibit the migration of BMSCs in mice, a process in which the signal pathway of Akt is involved in its regulation.
探讨交感神经递质去甲肾上腺素(NE)对小鼠骨髓间充质干细胞(BMSCs)迁移的影响及其机制。(1)处死20只3周龄雄性C57BL/6小鼠,从股骨和胫骨分离、培养并鉴定BMSCs。将第二代或第三代细胞分为磷酸盐缓冲液(PBS)组、1 μmol/L NE组、10 μmol/L NE组和100 μmol/L NE组,每组8孔。1 μmol/L NE组、10 μmol/L NE组和100 μmol/L NE组的细胞在含1%体积分数胎牛血清的低糖杜氏改良 Eagle培养基(以下简称低血清培养基)中培养,分别添加终浓度为1 μmol/L、10 μmol/L和100 μmol/L的NE。PBS组细胞在添加相同体积PBS的低血清培养基中培养。在刺激前(0天)及刺激第1、3、5天,采用细胞计数试剂盒8法检测细胞增殖活性(以吸光度值表示)。(2)在细胞划痕试验1中,将细胞分为PBS组和单纯NE组。划痕试验后,单纯NE组细胞在含终浓度为10 μmol/L NE的低血清培养基中培养,PBS组细胞在含相同体积PBS的低血清培养基中培养。在细胞划痕试验2中,将细胞分为PBS组、普萘洛尔+NE组和酚妥拉明+NE组。划痕试验后,普萘洛尔+NE组细胞每天用终浓度为1 μmol/L的普萘洛尔预处理30分钟,酚妥拉明+NE组细胞每天用终浓度为10 μmol/L的酚妥拉明预处理30分钟,然后在含终浓度为10 μmol/L NE的低血清培养基中培养。PBS组细胞在含相同体积PBS的低血清培养基中培养。在细胞划痕试验3中,将细胞分为单纯NE组、单纯(2E,6E)-2,6-双(4-吡啶基亚甲基)环己酮(SC-66)组和SC-66+NE组。划痕试验后,单纯NE组细胞在含终浓度为10 μmol/L NE的低血清培养基中培养,单纯SC-66组细胞每天用终浓度为30 mmol/L的SC-66预处理30分钟后在低血清培养基中培养,SC-66+NE组细胞每天用终浓度为30 mmol/L的SC-66预处理30分钟后在含终浓度为10 μmol/L NE的低血清培养基中培养。在上述3个细胞划痕试验中,每组样本数均为6,计算划痕后24、48和72小时的划痕愈合率。(3)将细胞分为PBS组、单纯NE组、普萘洛尔+NE组和酚妥拉明+NE组,每组3孔。PBS组和单纯NE组的下室处理方法与细胞划痕试验1中同组相同。普萘洛尔+NE组和酚妥拉明+NE组的下室处理方法与细胞划痕试验2中同组相同。进行Transwell实验并常规培养细胞24小时后,计数迁移的细胞。(4)将细胞分为PBS组、单纯NE组、普萘洛尔+NE组和酚妥拉明+NE组,每组2皿。PBS组和单纯NE组的细胞处理与细胞划痕试验1中同组相同。普萘洛尔+NE组和酚妥拉明+NE组的细胞处理与细胞划痕试验2中同组相同。常规培养24小时后,采用蛋白质免疫印迹法检测细胞中蛋白激酶B(Akt)的磷酸化水平。数据采用重复测量方差分析、单因素方差分析、独立样本t检验、最小显著差法检验和Bonferroni校正进行统计学分析。(1)刺激1天后,100 μmol/L NE组细胞的吸光度值显著低于PBS组(F = 2.9